Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-07-14 | Amended | $1,200,000 | $180,000 | Debt Only | 06b | SEC link |
2025-04-28 | New | $1,020,000 | $1,020,000 | Debt Only | 06b | SEC link |
Name | Role |
---|---|
Barbara Hibner | Director, Executive |
Michael Lipp | Executive |
Peter Klaus Marschel | Director, Executive |
Frederick Ernest Pierce | Director, Executive |